In the News

Keeping you up to date on everything happening
with Brixey & Meyer Capital.

Stillwater Technologies Adds Two Executives

DAYTON, Ohio and TROY, September 6, 2018 – Brixey & Meyer Capital, LLC and the Board of Managers of Stillwater Technologies, LLC (“Stillwater”) are pleased to announce the addition of two new executives. Dennis J. Miller has joined the company as Chief Executive Officer and John V. Handelsman has been elected Chairman.

Read more

Brixey & Meyer Capital Introduces David Herche to Growth Fund ll Investment Committee

DAYTON, Ohio and CINCINNATI, August 2018 – Brixey & Meyer Capital, LLC is pleased to announce that David Herche, Chairman of Enerfab, Inc. and Executive Chairman of West Chester Protective Gear has joined the Investment Committee for BMC Growth Fund II. Investment Committee members serve voluntarily and are responsible to govern all investment and capital strategy decisions with respect to the portfolio businesses and the income and value they generate. All Investment Committee members are also Fund investors.

Read more

Brixey & Meyer Capital Introduces New Member to Growth Fund II Investment Committee

DAYTON, Ohio and CINCINNATI, July 2018 -Brixey & Meyer Capital, LLC is pleased to announce that Claude Davis, Executive Chairman of First Financial Bank has joined the Investment Committee for BMC Growth Fund II.  Investment Committee members serve voluntarily and are responsible to govern all investment and capital strategy decisions with respect to the portfolio businesses and the income and value they generate.  All Investment Committee members are also Fund investors.

Read more

Brixey & Meyer Capital Growth Fund II Adds Two New Executives

DAYTON, Ohio and CINCINNATI, June 2018 – Brixey & Meyer Capital is pleased to announce the launch of Growth Fund II and the addition of two new executives to the team.

Pat Hobby has joined as Director of Shared Services and in this role, Pat is responsible for overseeing the back-office operations (finance, accounting, human resources, and IT) of the BMC portfolio companies.

John Handelsman has joined as Operating Partner and in this role, John will be principally responsible for catalyzing value creation in the portfolio businesses, coming alongside and supporting the CEO’s with strategic process, strategy development, performance management and performance coaching.

Read more

BMC ACQUIRES 3 SIGMA

DAYTON and CINCINNATI, Ohio, Sept. 18, 2017 — Brixey & Meyer Capital (collectively with its affiliated entities, “BMC”) announced today it has acquired 3 Sigma (or the “Company”).  Since 1980, 3 Sigma has been a specialty provider of adhesive coated materials to converters and manufacturers around the world.   3 Sigma utilizes its deep application experience and expertise in the chemistry of adhesive technology to serve the automotive, food, consumer products, medical and marketing industries.   3 Sigma’s technologies can be found in coated materials used in applications such as press and seal consumer packaging, security labels, construction tapes, brake pads and many other highly engineered applications.

Read more

BMC ACQUIRES STILLWATER TECHNOLOGIES

DAYTON, Ohio and CINCINNATI, Aug. 26, 2016 – Brixey & Meyer Capital (collectively with its affiliated entities, “BMC”) announced today it has acquired Stillwater Technologies (“Stillwater”). Stillwater is a leading supplier of precision machining and resistance welding solutions to the communications, aerospace, defense, automotive and energy sectors. Stillwater was purchased from Bill and Wanda Lukens.

Read more

Final Closing of BMC Growth Fund

DAYTON, Ohio and CINCINNATI, Aug. 16, 2016 – Brixey & Meyer Capital (“BMC”) announced today it has held its final closing of the BMC Growth Fund, LLC.  This final closing held on July 18, 2016 resulted in total commitments of approximately $18.0 million.  The fund’s investors are made up of successful entrepreneurs and private investors predominately from Southwest Ohio.

The fund was launched in November 2015 in conjunction with the first acquisition of the fund, Clinical Research Solutions.  Clinical Research Solutions (“CRS”) is headquartered in Cleveland, Ohio with locations throughout Ohio and Tennessee.  CRS performs phase I to IV clinical trials for large and small pharmaceutical companies across the world.

Read more